Daftar Login

@mole_4d

MEREK : mole 4d

@mole_4d

mole 4dShares of 4D Molecular Therapeutics more than doubled on Monday after the therapy developer reported results from a4D-175 combines the customized and evolved intravitreal vector, R100, and a codon-optimized transgene encoding a hhly functional shortened form of human complement factor H (sCFH).The genetic medicine candidate is desned to

IDR 10.000
IDR 100.000 Disc -90%
Kuantitas